Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Remdesivir is a nucleoside analogue, with effective antiviral activity( EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells)
Description | Remdesivir is a nucleoside analogue, with effective antiviral activity( EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells) |
Targets&IC50 | MERS-CoV:74 nM (EC50), SARS-CoV:74 nM (EC50) |
In vitro | GS-5734 inhibits murine hepatitis virus (MHV) with similar 50% effective concentration values (EC50) as SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV).?Passage of WT MHV in the presence of the GS-5734 parent nucleoside selected two mutations in the nsp12 polymerase at residues conserved across all CoVs that conferred up to 5.6-fold resistance to GS-5734, as determined by EC50[1]. |
Synonyms | DNA/RNA Synthesis, Remdesivir, GS 5734, COVID-19, MERS-CoV, 2019-nCoV, antiviral, SARS coronavirus, Inhibitor, GS5734, SARS-CoV, GS-5734, inhibit, infection |
Molecular Weight | 602.585 |
Formula | C27H35N6O8P |
CAS No. | 1809249-37-3 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 125 mg/mL (207.44 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.